NCT03111134

Brief Summary

At present, open-type abdominal surgery is routine access into the abdomen. Median incision is the common choice with open-type abdominal surgery. Layered abdomen-closing is often used at the end-time of the surgery. There are some common postoperative complications, such as incision pain, surgical site infection, surgical incision dehiscence and incisional hernia. The key to reduce the incidence of postoperative complications depends on safe and reliable technology of abdomen-closing. It's usually difficult to close the abdomen after the incisional hernia surgery, and the recurrence of incisional hernia is high. But the recurrence fell off observably when component separation technology was applied to abdomen-closing of incisional hernia. Based on this, we hypothesis that modified-CST applied to abdomen-closing in routine abdominal surgery may improve the quality of wound-healing. In this prospective single-blind randomized controlled trial, traditional abdomen-closing technology and modified-CST will be used to gastric cancer surgery, and the quality of wound-healing will be evaluated to confirm which kind of abdomen-closing technology better.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 12, 2017

Completed
19 days until next milestone

Study Start

First participant enrolled

May 1, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

April 12, 2017

Status Verified

April 1, 2017

Enrollment Period

1.5 years

First QC Date

April 7, 2017

Last Update Submit

April 7, 2017

Conditions

Keywords

abdominal wound closure techniqueslayered closurecomponent separation technique

Outcome Measures

Primary Outcomes (1)

  • Class A healing rate of the surgical incision

    Class A healing rate of the surgical incision after operation

    1 month

Secondary Outcomes (9)

  • the incidence rate of incisional complications

    1 month

  • the time of suture to clear

    1 month

  • hospitalization time after operation

    1 year

  • the incidence rate of unplanned second operation

    1 month

  • the incidence rate of unplanned readmission

    1 month

  • +4 more secondary outcomes

Study Arms (2)

Routine Abdominal Closure

NO INTERVENTION

New Abdominal Closure

EXPERIMENTAL

modified component separation technique is used to abdomen closing.

Procedure: modified component separation technique

Interventions

a new abdomen closure technique based on component separation technique

New Abdominal Closure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients \>18 years of age
  • undergoing gastric cancer surgery
  • undergoing abdominal surgery first time
  • median upper abdominal incision applied (length of incision \> 5cm)
  • randomly select abdominal closure technique agreed by patients and family members

You may not qualify if:

  • women who pregnant
  • coagulation disorders
  • undergoing immunological therapy
  • undergoing chemothearphy within 2 weeks before the surgery
  • undergoing Abdominal radiotherapy within 8 weeks before the surgery
  • spirit disease patients
  • the expecting life span less than 48 hours
  • no guarantees to follow-up for 3 years
  • patients with poor compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing Hospital

Xi’an, Shanxi, 710032, China

Location

Study Officials

  • Xiaonan Liu, Ph.D

    Xijing Hospital

    STUDY CHAIR

Central Study Contacts

Xiaonan Liu, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

April 7, 2017

First Posted

April 12, 2017

Study Start

May 1, 2017

Primary Completion

October 31, 2018

Study Completion

December 31, 2018

Last Updated

April 12, 2017

Record last verified: 2017-04

Locations